22nd Century Group (NASDAQ:XXII) Research Coverage Started at StockNews.com

StockNews.com started coverage on shares of 22nd Century Group (NASDAQ:XXII) in a research report report published on Wednesday morning. The firm issued a hold rating on the biotechnology company’s stock.

22nd Century Group Trading Down 5.1 %

XXII opened at $4.99 on Wednesday. The company has a quick ratio of 0.93, a current ratio of 1.09 and a debt-to-equity ratio of 1.59. 22nd Century Group has a 52 week low of $3.90 and a 52 week high of $581.85. The business’s 50 day moving average is $11.79 and its two-hundred day moving average is $49.17. The firm has a market cap of $1.71 million, a price-to-earnings ratio of -0.23 and a beta of 1.50.

22nd Century Group (NASDAQ:XXII) last posted its quarterly earnings data on Tuesday, November 12th. The biotechnology company reported ($72.90) earnings per share for the quarter. 22nd Century Group had a negative return on equity of 380.39% and a negative net margin of 144.09%. The company had revenue of $5.95 million for the quarter.

Institutional Investors Weigh In On 22nd Century Group

A hedge fund recently bought a new stake in 22nd Century Group stock. Anson Funds Management LP purchased a new position in 22nd Century Group, Inc. (NASDAQ:XXII) during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 3,140,452 shares of the biotechnology company’s stock, valued at approximately $691,000. Anson Funds Management LP owned about 6.77% of 22nd Century Group at the end of the most recent quarter. Institutional investors own 18.06% of the company’s stock.

22nd Century Group Company Profile

22nd Century Group, Inc, a tobacco products company, engages in the sale and distribution of its own proprietary new reduced nicotine tobacco products. The company offers reduced nicotine content tobacco plants and very low nicotine combustible cigarette products. It also provides contract manufacturing services for conventional combustible tobacco products for third-party brands.